R. Treede, T. Jensen, and J. Campbell, Neuropathic pain: Redefinition and a grading system for clinical and research purposes, Neurology, vol.70, issue.18, pp.1630-1635, 2008.
DOI : 10.1212/01.wnl.0000282763.29778.59

. Pickering, Memantine before mastectomy prevents post-surgery pain: a randomized, blinded clinical trial in surgical patients, PLoS One, vol.11, issue.4, p.152741, 2016.

G. Pickering, G. Gavazzi, J. Gaillat, M. Paccalin, K. Bloch et al., Is herpes zoster an additional complication in old age alongside comorbidity and multiple medications? Results of the post hoc analysis of the 12-month longitudinal prospective observational ARIZONA cohort study, BMJ Open, vol.372, issue.1, p.9689, 2016.
DOI : 10.1056/NEJMoa1501184

G. Gavazzi, H. Zoster, . Consortium, G. Pickering, and K. Schmader, Functional decline and herpes zoster in older people: an interplay of multiple factors, Aging Clin Exp Res, vol.27, issue.6, pp.757-765, 2015.

D. Bouhassira, M. Lantéri-minet, N. Attal, B. Laurent, and C. Touboul, Prevalence of chronic pain with neuropathic characteristics in the general population, Pain, vol.136, issue.3, pp.380-387, 2008.
DOI : 10.1016/j.pain.2007.08.013
URL : https://hal.archives-ouvertes.fr/inserm-00326893

P. Marchettini, M. Lacerenza, E. Mauri, and C. Marangoni, Painful Peripheral Neuropathies, Current Neuropharmacology, vol.4, issue.3, pp.175-181, 2006.
DOI : 10.2174/157015906778019536

M. Brown, J. Ramirez, and P. Farquhar-smith, Pain in cancer survivors, British Journal of Pain, vol.10, issue.1, pp.139-153, 2014.
DOI : 10.1016/j.pain.2007.10.012

G. Mick and G. Correa-illanes, Topical pain management with the 5% lidocaine medicated plaster ??? a review, Current Medical Research and Opinion, vol.28, issue.6, pp.937-951, 2012.
DOI : 10.1185/03007995.2012.690339

R. Dworkin, O. Connor, A. Backonja, and M. , Pharmacologic management of neuropathic pain: Evidence-based recommendations, Pain, vol.132, issue.3, pp.237-251, 2007.
DOI : 10.1016/j.pain.2007.08.033

O. Van-hecke, P. Kamerman, and N. Attal, Neuropathic pain phenotyping by international consensus (NeuroPPIC) for genetic studies, PAIN, vol.156, issue.11, pp.2337-2353, 2015.
DOI : 10.1097/j.pain.0000000000000335

Y. Deng, L. Luo, Y. Hu, K. Fang, and J. Liu, Clinical practice guidelines for the management of neuropathic pain: a systematic review, BMC Anesthesiology, vol.306, issue.3, p.12, 2016.
DOI : 10.1007/s00403-013-1394-x

N. Finnerup, N. Attal, and S. Haroutounian, Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis, The Lancet Neurology, vol.14, issue.2, pp.162-173, 2015.
DOI : 10.1016/S1474-4422(14)70251-0

G. Mick, R. Baron, and N. Finnerup, What is localized neuropathic pain? A first proposal to characterize and define a widely used term, Pain Management, vol.4, issue.1, pp.71-77, 2012.
DOI : 10.1097/SPC.0b013e3282f57da5

R. Casale, Z. Symeonidou, and M. Bartolo, Topical Treatments for Localized Neuropathic Pain, Current Pain and Headache Reports, vol.630, issue.9, p.15, 2017.
DOI : 10.1007/s00482-015-0060-y

S. Derry, P. Wiffen, and E. Kalso, Topical analgesics for acute and chronic pain in adults - an overview of Cochrane Reviews, Cochrane Database of Systematic Reviews, vol.348, issue.7, p.8609, 2017.
DOI : 10.1002/14651858.CD008609

A. Berger, E. Dukes, and G. Oster, Clinical characteristics and economic costs of patients with painful neuropathic disorders, The Journal of Pain, vol.5, issue.3, pp.143-149, 2004.
DOI : 10.1016/j.jpain.2003.12.004

B. Yawn, P. Wollan, T. Weingarten, J. Watson, W. Hooten et al., The Prevalence of Neuropathic Pain: Clinical Evaluation Compared with Screening Tools in a Community Population, Pain Medicine, vol.11, issue.1, pp.586-593, 2009.
DOI : 10.1016/S0733-8619(05)70097-9

M. Bennett, The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs, Pain, vol.92, issue.1, pp.147-157, 2001.
DOI : 10.1016/S0304-3959(00)00482-6

M. Bennett, B. Smith, N. Torrance, and J. Potter, The S-LANSS score for identifying pain of predominantly neuropathic origin: Validation for use in clinical and postal research, The Journal of Pain, vol.6, issue.3, pp.149-158, 2005.
DOI : 10.1016/j.jpain.2004.11.007

P. Fine, Chronic Pain Management in Older Adults: Special Considerations, Journal of Pain and Symptom Management, vol.38, issue.2, pp.4-14, 2009.
DOI : 10.1016/j.jpainsymman.2009.05.002

R. Baron, A. Binder, and G. Wasner, Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment, The Lancet Neurology, vol.9, issue.8, pp.807-819, 2010.
DOI : 10.1016/S1474-4422(10)70143-5

C. Dualé, L. Ouchchane, P. Schoeffler, . Edonis-investigating-group, and C. Dubray, Neuropathic Aspects of Persistent Postsurgical Pain: A French Multicenter Survey With a 6-Month Prospective Follow-Up, The Journal of Pain, vol.15, issue.1, pp.24-25, 2014.
DOI : 10.1016/j.jpain.2013.08.014

Y. Golan-vered and D. Pud, Chemotherapy-Induced Neuropathic Pain and Its Relation to Cluster Symptoms in Breast Cancer Patients Treated with Paclitaxel, Pain Practice, vol.13, issue.1, pp.46-52, 2013.
DOI : 10.1111/j.1529-8027.2008.00156.x

I. Kohama, K. Ishikawa, and J. Kocsis, Synaptic reorganization in the substantia gelatinosa after peripheral nerve neuroma formation: aberrant innervation of lamina II neurons by Abeta afferents, J Neurosci, vol.20, issue.4, pp.1538-1549, 2000.

C. Woolf and S. Thompson, The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states, Pain, vol.44, issue.3, pp.293-299, 1991.
DOI : 10.1016/0304-3959(91)90100-C

G. Pickering, B. Pereira, E. Dufour, S. Soule, and C. Dubray, Impaired Modulation of Pain in Patients with Postherpetic Neuralgia, Pain Research and Management, vol.19, issue.1, pp.19-23, 2014.
DOI : 10.1155/2014/507947

K. Bannister, R. Patel, L. Goncalves, L. Townson, and A. Dickenson, Diffuse noxious inhibitory controls and nerve injury, PAIN, vol.156, issue.9, pp.1803-1811, 2015.
DOI : 10.1097/j.pain.0000000000000240

A. Dubin and A. Patapoutian, Nociceptors: the sensors of the pain pathway, Journal of Clinical Investigation, vol.120, issue.11, pp.3760-3772, 2010.
DOI : 10.1172/JCI42843

L. Marwaha, Y. Bansal, R. Singh, P. Saroj, R. Bhandari et al., TRP channels: potential drug target for neuropathic pain, Inflammopharmacology, vol.8, issue.6, pp.305-317, 2016.
DOI : 10.1186/1744-8069-8-55

P. Mäntyselkä, E. Kumpusalo, and R. Ahonen, Pain as a reason to visit the doctor: a study in Finnish primary health care, Pain, vol.89, issue.2, pp.2-3, 2001.
DOI : 10.1016/S0304-3959(00)00361-4

D. Bouhassira, N. Attal, and H. Alchaar, Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4), Pain, vol.114, issue.1, pp.29-36, 2005.
DOI : 10.1016/j.pain.2004.12.010

R. Freynhagen, R. Baron, U. Gockel, and T. Tölle, : a new screening questionnaire to identify neuropathic components in patients with back pain, Current Medical Research and Opinion, vol.22, issue.10, pp.1911-1920, 2006.
DOI : 10.1185/030079906X132488

G. Mick, R. Baron, and G. Correa-illanes, Is an easy and reliable diagnosis of localized neuropathic pain (LNP) possible in general practice? Development of a screening tool based on IASP criteria, Current Medical Research and Opinion, vol.30, issue.7, pp.1357-1366, 2014.
DOI : 10.1185/03007995.2014.907562

G. Pickering, B. Pereira, and F. Clère, Cognitive Function in Older Patients with Postherpetic Neuralgia, Pain Practice, vol.58, issue.1, pp.1-7, 2014.
DOI : 10.1507/endocrj.EJ11-0095

O. De-león-casasola and V. Mayoral, The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence, Journal of Pain Research, vol.9, pp.67-79, 2016.
DOI : 10.2147/JPR.S99231

N. Attal, G. Cruccu, and R. Baron, EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision, European Journal of Neurology, vol.138, issue.Suppl, pp.1113-88, 2010.
DOI : 10.1016/j.pain.2008.01.006

A. Gammaitoni, N. Alvarez, and B. Galer, Safety and Tolerability of the Lidocaine Patch 5%, a Targeted Peripheral Analgesic: A Review of the Literature, The Journal of Clinical Pharmacology, vol.16, issue.2, pp.111-117, 2003.
DOI : 10.1097/00002508-200009000-00005

M. Sheets and D. Hanck, Molecular Action of Lidocaine on the Voltage Sensors of Sodium Channels, The Journal of General Physiology, vol.6, issue.1, pp.163-175, 2003.
DOI : 10.1016/S0006-3495(93)81292-X

M. Sheets and D. Hanck, Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels, The Journal of Physiology, vol.65, issue.1
DOI : 10.1016/S0006-3495(93)81042-7

T. Meier, G. Wasner, and M. Faust, Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study, Pain, vol.106, issue.1, pp.151-158, 2003.
DOI : 10.1016/S0304-3959(03)00317-8

T. Meier, M. Faust, M. Hüppe, and P. Schmucker, Reduktion chronischer Schmerzen bei nichtpostherpetischen peripheren Neuropathien nach topischer Behandlung mit Lidocainpflaster. [Reduction of chronic pain for non-postherpetic peripheral neuropathies after topical treatment with a lidocaine patch], Schmerz, vol.18, issue.3, pp.172-178, 2004.
DOI : 10.1007/s00482-003-0272-4

S. Rehm, A. Binder, and R. Baron, Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study, Current Medical Research and Opinion, vol.26, issue.7, pp.1607-1619, 2010.
DOI : 10.1185/03007995.2010.483675

V. Lam, M. Wallace, and G. Schulteis, Effects of Lidocaine Patch on Intradermal Capsaicin-Induced Pain: A Double-Blind, Controlled Trial, The Journal of Pain, vol.12, issue.3, pp.323-330, 2011.
DOI : 10.1016/j.jpain.2010.07.013

E. Krumova, M. Zeller, A. Westermann, and C. Maier, Lidocaine patch (5%) produces a selective, but incomplete block of A?? and C fibers, Pain, vol.153, issue.2, pp.273-280, 2012.
DOI : 10.1016/j.pain.2011.08.020

R. Baron, A. Binder, N. Attal, R. Casale, A. Dickenson et al., Neuropathic low back pain in clinical practice, European Journal of Pain, vol.14, issue.Suppl 2, pp.861-873, 2016.
DOI : 10.1111/pme.12143

. Emc, Versatis 5% Medicated Plaster ? Summary of Product Characteristics Available from: https://www. medicines.org.uk/emc/medicine, 2017.

B. Galer, M. Rowbotham, J. Perander, and E. Friedman, Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study, Pain, vol.80, issue.3, pp.533-538, 1999.
DOI : 10.1016/S0304-3959(98)00244-9

R. Baron, V. Mayoral, G. Leijon, A. Binder, I. Steigerwald et al., 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study, Current Medical Research and Opinion, vol.25, issue.7, pp.1663-1676, 2009.
DOI : 10.1185/03007990903047880

M. Navez, C. Monella, I. Bösl, D. Sommer, and C. Delorme, 5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability, Pain and Therapy, vol.130, issue.Suppl, pp.1-15, 2015.
DOI : 10.1016/j.pain.2007.03.036

I. Wilhelm, A. Tzabazis, R. Likar, R. Sittl, and N. Griessinger, Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster, European Journal of Anaesthesiology, vol.27, issue.2
DOI : 10.1097/EJA.0b013e328330e989

P. Mccormack, Capsaicin Dermal Patch, Drugs, vol.68, issue.12, pp.1831-1842, 2010.
DOI : 10.1503/cmaj.060146

M. Haanpää and R. Treede, Capsaicin for Neuropathic Pain: Linking Traditional Medicine and Molecular Biology, European Neurology, vol.18, issue.5, pp.264-275, 2012.
DOI : 10.1007/s005920200005

J. Sawynok, Topical and Peripherally Acting Analgesics, Pharmacological Reviews, vol.55, issue.1, pp.1-20, 2003.
DOI : 10.1124/pr.55.1.1
URL : http://pharmrev.aspetjournals.org/content/pharmrev/55/1/1.full.pdf

P. Anand and K. Bley, Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch, British Journal of Anaesthesia, vol.107, issue.4, pp.490-502, 2011.
DOI : 10.1093/bja/aer260

S. Derry, R. Lloyd, R. Moore, and H. Mcquay, Topical capsaicin for chronic neuropathic pain in adults, Cochrane Database Syst Rev, issue.4, p.7393, 2009.

S. Babbar, J. Marier, and M. Mouksassi, Pharmacokinetic Analysis of Capsaicin After Topical Administration of a High-Concentration Capsaicin Patch to Patients With Peripheral Neuropathic Pain, Therapeutic Drug Monitoring, vol.31, issue.4, pp.502-510, 2009.
DOI : 10.1097/FTD.0b013e3181a8b200

M. Thomson, Drug Information for the Health Care Professional, 2006.

C. Walpole, R. Wrigglesworth, and S. Bevan, Analogs of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 1. The aromatic "A-region", Journal of Medicinal Chemistry, vol.36, issue.16, pp.2362-2372, 1993.
DOI : 10.1021/jm00068a014

R. Mde, L. Gonzalez-mondragon, E. Vazquez-tzompantzi, and E. , Chemical and pharmacological aspects of capsaicin, Molecules, vol.16, issue.2, pp.1253-1270, 2011.

G. Irving, M. Backonja, R. Rauck, L. Webster, J. Tobias et al., NGX-4010, a Capsaicin 8% Dermal Patch, Administered Alone or in Combination With Systemic Neuropathic Pain Medications, Reduces Pain in Patients With Postherpetic Neuralgia, The Clinical Journal of Pain, vol.28, issue.2, pp.101-107, 2012.
DOI : 10.1097/AJP.0b013e318227403d

N. Ladjevic and I. Likic-ladjevic, Topical Glycopirrolate for the Management of Hyperhidrosis in Herpetic Neuralgia, Yonsei Medical Journal, vol.50, issue.2, pp.293-295, 2009.
DOI : 10.3349/ymj.2009.50.2.293

M. Haanpää, G. Gourlay, and J. Kent, Treatment Considerations for Patients With Neuropathic Pain and Other Medical Comorbidities, Mayo Clinic Proceedings, vol.85, issue.3, pp.15-25, 2010.
DOI : 10.4065/mcp.2009.0645

S. Derry, A. Rice, P. Cole, T. Tan, and R. Moore, Topical capsaicin (high concentration) for chronic neuropathic pain in adults, Cochrane Database Syst Rev, vol.1, p.7393, 2017.

S. Derry and R. Moore, Topical capsaicin (low concentration) for chronic neuropathic pain in adults, Cochrane Database of Systematic Reviews, vol.10, issue.4, p.10111, 2012.
DOI : 10.1002/14651858.CD007393.pub2

D. Lodge, The history of the pharmacology and cloning of ionotropic glutamate receptors and the development of idiosyncratic nomenclature, Neuropharmacology, vol.56, issue.1, pp.6-21, 2009.
DOI : 10.1016/j.neuropharm.2008.08.006

S. Ilkjaer, J. Dirks, J. Brennum, M. Wernberg, and J. Dahl, Effect of systemic N-methyl-D-aspartate receptor antagonist (dextromethorphan) on primary and secondary hyperalgesia in humans, British Journal of Anaesthesia, vol.79, issue.5, pp.600-605, 1997.
DOI : 10.1093/bja/79.5.600

V. Azevedo, G. Lauretti, N. Pereira, and M. Reis, Transdermal Ketamine as an Adjuvant for Postoperative Analgesia After Abdominal Gynecological Surgery Using Lidocaine Epidural Blockade, Anesthesia & Analgesia, vol.91, issue.6, pp.1479-1482, 2000.
DOI : 10.1097/00000539-200012000-00034
URL : http://pdfs.journals.lww.com/anesthesia-analgesia/2000/12000/Transdermal_Ketamine_as_an_Adjuvant_for.34.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1505451696841;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdOHIHwDOSay4QvwGGy628kyM/dmqkNfccIxHjOUB6MTH5vIapEC7F+Un5LesPgh4o;hash|10p0WSk9AHf/9dJ65z1/mQ==

J. Sawynok, Topical analgesics for neuropathic pain: Preclinical exploration, clinical validation, future development, European Journal of Pain, vol.60, issue.4, pp.465-481, 2014.
DOI : 10.1016/j.neuron.2008.08.024
URL : http://onlinelibrary.wiley.com/doi/10.1002/j.1532-2149.2013.00400.x/pdf

M. Anitescu, H. Benzon, and C. Argoff, Advances in topical analgesics, Current Opinion in Anaesthesiology, vol.26, issue.5, pp.555-561, 2013.
DOI : 10.1097/01.aco.0000432514.00446.22

D. Kopsky, K. Hesselink, J. Bhaskar, A. Hariton, G. Romanenko et al., Analgesic effects of topical ketamine, Minerva Anestesiol, vol.81, issue.4, pp.440-449, 2015.

S. Bajaj, A. Whiteman, and B. Brandner, Transdermal drug delivery in pain management, Continuing Education in Anaesthesia Critical Care & Pain, vol.11, issue.2, pp.39-43, 2011.
DOI : 10.1093/bjaceaccp/mkq054

M. Wallace, D. Kudrow, and W. Mcelveen, Clinical trial results: a randomized, double-blind, placebo-controlled trial of a three-day bupivacaine patch (ELADUR?) in patients with post-herpetic neuralgia. Poster session presented at: The American Pain Society 27th Annual Meeting, 2008.

F. Alessandri, D. Lijoi, E. Mistrangelo, A. Nicoletti, M. Crosa et al., Topical diclofenac patch for postoperative wound pain in laparoscopic gynecologic surgery: A randomized study, Journal of Minimally Invasive Gynecology, vol.13, issue.3, pp.195-200, 2006.
DOI : 10.1016/j.jmig.2006.02.001

S. Stanos and K. Galluzzi, Topical Therapies in the Management of Chronic Pain, Postgraduate Medicine, vol.125, issue.sup1, pp.25-33, 2013.
DOI : 10.1080/00325481.2013.1110567111

L. Jorge, C. Feres, and V. Teles, Topical preparations for pain relief: efficacy and patient adherence, J Pain Res, vol.4, pp.11-24, 2010.

B. Mazières, Topical Ketoprofen Patch, Drugs in R & D, vol.31, issue.11, pp.337-344, 2005.
DOI : 10.2165/00126839-200506060-00003

S. Ahmed, Y. Zhang, and L. Chen, Effect of 1.5% Topical Diclofenac on Clinical Neuropathic Pain, Anesthesiology, vol.123, issue.1, pp.191-198, 2015.
DOI : 10.1097/ALN.0000000000000693

O. Rascol, T. Zesiewicz, and K. Chaudhuri, A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain, The Journal of Clinical Pharmacology, vol.81, issue.6, pp.852-861, 2016.
DOI : 10.1016/j.neuron.2014.02.042

P. Gerner, G. Kao, V. Srinivasa, S. Narang, and G. Wang, Topical amitriptyline in healthy volunteers, Reg Anesth Pain Med, vol.28, issue.4, pp.289-293, 2003.

J. Leclaire, O. De-lacharriere, L. Breton, L. Societe, and S. Oreal, Cosmetic/ pharmaceutical compositions comprising ?-adrenergic agonists/ substance P antagonists. US patent 5958432, 1999.

P. Juif, M. Melchior, and P. Poisbeau, Characterization of the fast GABAergic inhibitory action of etifoxine during spinal nociceptive processing in male rats, Neuropharmacology, vol.91, pp.117-122, 2015.
DOI : 10.1016/j.neuropharm.2014.12.022

M. Allegri, R. Baron, and G. Hans, A pharmacological treatment algorithm for localized neuropathic pain, Current Medical Research and Opinion, vol.32, issue.2, pp.377-384, 2016.
DOI : 10.1185/03007995.2015.1129321

S. Derry, A. Sven-rice, P. Cole, T. Tan, and R. Moore, Topical capsaicin (high concentration) for chronic neuropathic pain in adults, Cochrane Database Syst Rev, issue.2, p.7393, 2013.

R. Barkin, The Pharmacology of Topical Analgesics, Postgraduate Medicine, vol.125, issue.sup1, pp.7-18, 2013.
DOI : 10.1080/00325481.2013.1110566911

G. Pickering, Antiepileptics for Post-Herpetic Neuralgia in the Elderly: Current and Future Prospects, Drugs & Aging, vol.38, issue.6, pp.653-660, 2014.
DOI : 10.1016/j.tibs.2013.03.003

G. Pickering and D. Lussier, Neuropathic pain Pain Management in the Elderly Patient: A Comprehensive Guide to Diagnosis and Treatment, 2017.

E. Hajjar, A. Cafiero, and J. Hanlon, Polypharmacy in elderly patients, The American Journal of Geriatric Pharmacotherapy, vol.5, issue.4, pp.345-351, 2007.
DOI : 10.1016/j.amjopharm.2007.12.002

L. Priano, M. Gasco, and A. Mauro, Transdermal Treatment Options for Neurological Disorders, Drugs & Aging, vol.60, issue.7, pp.357-375, 2006.
DOI : 10.1212/01.WNL.0000055848.00032.39

R. Casale and C. Mattia, Building a diagnostic algorithm on localized neuropathic pain (LNP) and targeted topical treatment: focus on 5% lidocaine-medicated plaster, Therapeutics and Clinical Risk Management, vol.10, pp.259-268, 2014.
DOI : 10.2147/TCRM.S58844

D. Seminowicz and K. Davis, A re-examination of pain???cognition interactions: Implications for neuroimaging, Pain, vol.130, issue.1, pp.8-13, 2007.
DOI : 10.1016/j.pain.2007.03.036

C. Oluigbo, A. Salma, and A. Rezai, Targeting the affective and cognitive aspects of chronic neuropathic pain using basal forebrain neuromodulation: Rationale, review and proposal, Journal of Clinical Neuroscience, vol.19, issue.9, pp.1216-1221, 2012.
DOI : 10.1016/j.jocn.2012.04.002

G. Wolfe and R. Barohn, Painful peripheral neuropathy, Current Treatment Options in Neurology, vol.1, issue.suppl 9, pp.177-188, 2002.
DOI : 10.1212/WNL.51.6.1682

G. Pickering, Impact of 5% lidocaine medicated plaster on allodynic symptoms of localized neuropathic pain after knee surgery Available from: https://clinicaltrials.gov/ct2/show/NCT02763592?ter m=pickering+line&rank=1, 2017.

S. Frost, Treatment of complex regional pain syndrome type 1 in a pediatric patient using the lidocaine patch 5%: a case report, Current Therapeutic Research, vol.64, issue.8, pp.626-629, 2003.
DOI : 10.1016/j.curtheres.2003.09.010

S. Nayak and M. Cunliffe, Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: report of five cases, Pediatric Anesthesia, vol.175, issue.6, pp.554-558, 2008.
DOI : 10.1111/j.1526-4637.2005.00058.x

J. Rasolofo, M. Poncelet, V. Rousseau, and P. Marec-berard, Efficacit?? des empl??tres de lidoca??ne 5??% sur les douleurs des crises vaso-occlusives chez l???enfant dr??panocytaire, Archives de P??diatrie, vol.20, issue.7, pp.762-767, 2013.
DOI : 10.1016/j.arcped.2013.04.013

S. Friedrichsdorf and A. Nugent, Management of neuropathic pain in children with cancer, Current Opinion in Supportive and Palliative Care, vol.7, issue.2, pp.131-138, 2013.
DOI : 10.1097/SPC.0b013e3283615ebe

M. Fitzgerald, The development of nociceptive circuits, Nature Reviews Neuroscience, vol.19, issue.Suppl., pp.507-520, 2005.
DOI : 10.1083/jcb.134.2.487

G. Sarbacker, Topical therapies for chronic pain management: a review of diclofenac and lidocaine, US Pharm, vol.40, issue.3, pp.35-38, 2015.

H. Groninger and R. Schisler, Topical Capsaicin for Neuropathic Pain #255, Journal of Palliative Medicine, vol.15, issue.8, pp.946-947, 2012.
DOI : 10.1089/jpm.2012.9571

N. Üçeyler and C. Sommer, High-Dose Capsaicin for the Treatment of Neuropathic Pain: What We Know and What We Need to Know, Pain and Therapy, vol.17, issue.2, pp.73-84, 2014.
DOI : 10.1002/j.1532-2149.2013.00415.x

D. Simpson, J. Robinson-papp, and J. Van, Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study, The Journal of Pain, vol.18, issue.1, pp.42-53, 2017.
DOI : 10.1016/j.jpain.2016.09.008

J. Mogil, Sex differences in pain and pain inhibition: multiple explanations of a controversial phenomenon, Nature Reviews Neuroscience, vol.37, issue.12, pp.859-866, 2012.
DOI : 10.1016/j.joen.2011.03.007